5803
Why Does Allergy Lag Behind Rheumatology in Approved Biotech Drugs?
Tuesday, February 24, 2015: 3:30 PM-4:45 PM
Convention Center, Level Three, Room 332
1.25 CME/ 1.50 CE
Moderator:
Calman Prussin , MD FAAAAI

Learning Objectives

  1. Discuss mechanistic approaches to allergic disease therapy
  2. Develop insights into allergic disease drug discovery and development
  3. Identify potential obstructions to the development of biotech drugs in Allergy
3:30 PM
Basic Science Perspectives
Calman Prussin, MD FAAAAI
3:45 PM
Clinical Investigator Perspectives
Thomas B. Casale, MD FAAAAI
4:00 PM
Biotech Pharma Perspectives
David M. Essayan, MD FAAAAI
4:15 PM
Question & Answer
See more of: Q & A Workshop